|
|
||||||||
Abramson Family Cancer Research Institute and Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| Abstract |
|---|
|
|
|---|
and IL-4 activity during Th1 and Th2 maturation, respectively. We also show that a genetic interaction between T-bet and its target Hlx seems to be required for Th1 maturation, but that Hlx may also be dispensable for maintenance of a transcriptionally permissive ifng gene. In parallel to progressive activator independence in the permissive lineage, the ifng gene becomes more recalcitrant to switching as the forbidden lineage matures. T-bet plus Hlx can disrupt ifng silencing when introduced into developing Th2 cells, but they fail to perturb ifng silencing in mature Th2 cells. In contrast, a hypermorphic allele of T-bet can reverse silencing of the ifng gene in mature Th2 cells. These results suggest that signature gene activity of helper T cells is initially plastic but later becomes epigenetically fixed and offer an initial strategy for inducing mature cells to switch their fate. | Introduction |
|---|
|
|
|---|
and lymphotoxin-
, whereas Th2 secrete IL-4, IL-5, and IL-13. Th1 cells mediate protective responses against intracellular pathogens and tumors, whereas Th2 cells are necessary for the resistance to extracellular microbes (1). Generation of Th1 and Th2 cells depends on the fine regulation of transcription, allowing activation of cytokine genes in a subset-specific manner (1, 2, 3). T-bet is a T-box transcription factor that specifies Th1 lineage commitment, by inducing lineage-restricted target genes such as ifng and il12rb2 (4, 5, 6, 7, 8). GATA-3 is a zinc finger-containing transcription factor that specifies Th2 lineage commitment, including the induction of the Il4, Il13, and Il5 genes (9, 10, 11, 12, 13).
Numerous studies have suggested that activation of the ifng and il4 loci involves derepression of chromatin-based gene silencing that is mediated by the effects of T-bet and GATA-3, respectively (reviewed in Refs.3, 14, 15). Despite evidence for the essential roles of T-bet and GATA-3 in the induction of lineage-restricted gene activity, their contributions to maintaining heritable patterns of Th1 and Th2 gene expression have remained largely undefined. In developing Th1 cells, induction of IFN-
is blocked by a dominant-negative (DN)3 form of T-bet (7). In a Th1 clone, the reiteration of IFN-
expression is remarkably unaffected by DN T-bet, despite the antagonism of IL-12R
2 expression by DN T-bet in the same clone. Conditional gene deletion of Tbet has not yet been performed, but conditional deletion of gata3 indicates some parallel behavior (12, 13). IL-4 induction is sensitive to loss of GATA-3 developing Th2 cells. In mature Th2 cells, reiteration of IL-4 becomes less GATA-3 dependent, even though IL-5 and IL-13 remain highly dependent on GATA-3.
Using a series of DN transcription factors, we now report that the induction of heritable gene activity can be experimentally separable from the maintenance of that activity. The signature genes of mature helper T cells, ifng and il4, appear to transit from a state of genetically sensitive plasticity to a state of epigenetic fixation. Using a hypermorphic form of T-bet, we now also show that the progressive inability to switch on the ifng gene during Th2 maturation can be readily overcome with a strong variant trans-activator. Together, these results provide critical mechanistic insight into why lineage commitment of helper T cells is so responsive to extrinsic signals and their downstream mediators but why mature cells become recalcitrant to loss or gain of the same inductive signaling. These studies also provide an initial proof-of-concept that genetic strategies may be capable of switching what were previously regarded as fixed states of differentiation.
| Materials and Methods |
|---|
|
|
|---|
C57BL/6, Sv129, and DO11 TCR transgenic mice were purchased from commercial sources (Taconic Farms). B6 x 129 T-bet-deficient (T-bet/) mice were generated by deleting exons 26.
exon 26 mice are phenotypically identical with mice carrying a deletion of exon 1 (Refs.8, 16 and data not shown). Animal work was performed in accordance with guidelines of the University of Pennsylvania Animal Care and Use Committee.
T cell differentiation
CD4+ T cells from naive mice were stimulated with syngeneic APCs plus soluble anti-CD3 (1 µg/ml), anti-CD28 (0.5 µg/ml), and human rIL-2 (20 U/ml; Roche), as described (9). Experimental Th1 conditions included rIL-12 (5 ng/ml; BD Biosciences) plus
IL-4 (10 µg/ml). Experimental Th2 conditions included rIL-4 (5 U/ml; Roche) and
IL-12 (10 µg/ml). Restimulation was performed using PMA/ionomycin or plate-bound anti-CD3 where indicated, as previously described (7, 16). Th1 clone PGL2 was originally used to identify Hlx as a Th1-specific transcript by microarray (7). Th1 clone 9.1-2 protects BALB/c mice from Leishmania infection (17).
Retroviral gene transduction
Bicistronic retrovirus (RV) vectors were constructed as described previously (7). In some experiments, HLX bicistronic RV with truncated hCD8 was used to mark cells (18). Construction of DN Hlx, DN GATA-3, and T-bet-VP16 were performed with PCR mutagenesis. For DN Hlx, the central portion of the Hlx homeoprotein (aas 266346), including the DNA binding domain, was fused to the amino-terminal repression domain of the Drosophila engrailed repressor (dEnR; aas 1299). For DN GATA-3, the central portion of the protein (aas 259385), including the zinc finger-containing DNA binding domain (aa 263341), was fused to the amino-terminal repression domain of dEnR (aas 1299). For T-bet-VP16, the carboxy-terminal region of T-bet was deleted, and the NH2-terminal region, including the T-box (aas 1371) of T-bet, was fused to the trans-activation domain of HSV protein VP16 (aas 410490). Infection of T cells was performed as described (7).
Real-time PCR and Northern blotting
RT-PCR assays were performed as described (7) using an ABI Prism 7900 BioDetector (Applied Biosystems). All PCR data are levels of test gene over hypoxanthine phosphoribosyltransferase levels, with the lowest value standardized at 1. Northern blotting was performed as described (16).
Mammalian two-hybrid assay
Full-length T-bet and Hlx were fused to Gal4 DNA binding domain and VP16 trans-activation domains, respectively (CheckMate Mammalian Two Hybrid assay kit; Promega). pGal4-T-bet, pVP16-Hlx, and controls were cotransfected into 293T cells with a plasmid-encoding luciferase driven by five Gal4-response elements (pG5Luc). Forty-eight hours after transfection, Firefly and Renilla reniformis luciferase were measured using the Dual-Glo luciferase assay system (Promega).
| Results |
|---|
|
|
|---|
Attempts to dissect the genetic program that culminates in Th1 cell maturation led to the identification of the homeobox gene, Hlx (for H 2.0-like homeobox) as a Th1-specific transcription factor that appeared to drive maturation of IFN-
activity in cooperation with T-bet (7). Hlx mRNA was found to be preferentially expressed in Th1 cells (Fig. 1A), as suggested (7, 19), but is strictly dependent on (Fig. 1B) and quantitatively regulated by (Fig. 1C) T-bet. This is the first gene ablation evidence to directly demonstrate that T-bet is essential to induce Hlx, as prior evidence relied on overexpression of wild-type and DN factors (7). Once T-bet induces Hlx, they cooperate to induce maturation of IFN-
activity in a cell-intrinsic manner. This can be modeled in developing Th2 cells transduced with either T-bet alone or Hlx plus T-bet, all cultured within the same well (Fig. 1D). This effect is best demonstrated by the dramatic increase in amount of IFN-
produced per cell, as reflected in mean fluorescence intensity (MFI), or by secretion of IFN-
from sorted cells (Fig. 1D). Similar results were obtained with enriched naive cells from D011 TCR transgenic Rag2/ mice (data not shown).
|
might be mediated by a physical interaction, we used the mammalian two-hybrid assay (20), which monitors the ability of two proteins to bring tethered trans-activation and DNA binding domains in proximity. Cotransfection of Gal4-T-bet and VP16-Hlx (Fig. 1E) resulted in a specific and significant increase in luciferase activity (Fig. 1F). T-bet and Hlx might, therefore, physically interact to mediate their synergistic effects on transcription (Fig. 1D), a behavior described in other T-box/homeobox factor partnerships (21, 22, 23).
Hlx may be required for establishment but not maintenance of IFN-
activity
The foregoing data support a model of feed-forward gene induction, whereby T-bet induces Hlx, which then cooperates with its inducer, T-bet, to promote IFN-
maturation in a cell-intrinsic manner. Hlx gene deletion results in embryonic lethality (24). To address the requirement for Hlx in mediating IFN-
production, we, instead, used a strategy that has been used to successfully antagonize the function of other homeodomain proteins (25, 26). We constructed a RV consisting of the Hlx DNA binding domain fused to the repression domain of the dEnR protein (Fig. 2A).
|
synthesis, manifest primarily as reduced MFI of intracellular staining of IFN-
per cell (Fig. 2B). DN T-bet (7), however, resulted in a more severe defect, manifest primarily as reduced percentage of cells with intracellular staining of IFN-
. Analysis of IFN-
secretion by ELISA also revealed defects from both constructs (Fig. 2C). Identical results were obtained in DO11.10 transgenic T cells (data not shown). As further demonstration that this loss-of-function approach mirrors gain-of-function experiments, we evaluated expression of IL12R
2. Antagonism of T-bet but not of Hlx resulted in impaired IL12R
2 mRNA expression (Fig. 2D). These observations are consistent with the synergistic cooperation between T-bet and Hlx when inducing IFN-
production, but not IL12R
2 expression in developing Th2 cells (Fig. 1D; Ref.7). Curiously, neither DN Hlx nor DN T-bet significantly altered the expression of IL-4 or GATA-3 in developing Th2 cells (data not shown).
Using a long-term Th1 clone, we had previously suggested that T-bet might not be required for maintenance of IFN-
activity (7). We wished to further test this model by asking whether T-bet or Hlx is responsible for maintaining the heritably permissive state of IFN-
activity in newly maturing Th1 cells. We therefore performed a kinetic analysis. DO11.10 transgenic helper T cells were activated with APC/peptide in Th1-polarizing conditions. Cells were transduced with control, DN Hlx, or DN T-bet RVs at days 2, 9, 16, or 23, and IFN-
expression was analyzed 5 days after transduction. As Th1 maturation progressed, expression of IFN-
became recalcitrant to the effects of the DN factors (Fig. 2E). Antagonism of Hlx was still evident after 2 days, as reflected in reduced MFI of IFN-
staining, but was negligible after 1 wk. Cotransduction of DN T-bet and DN Hlx also had no effect on the ability to reiterate IFN-
activity (data not shown). Thus, establishment and maintenance of IFN-
activity in Th1 cells are experimentally distinguishable by their sensitivity and recalcitrance to DN transcription factors, respectively.
The DN T-bet construct may influence multiple targets (il12rb2, ifng, hlx, tbet). Conditional gene deletion or RNA interference will therefore be important follow-up approaches to test the validity of the model that T-bet and Hlx exhibit a hit-and-run behavior in activating the ifng gene. Despite the relatively high levels of Hlx during the first few days of Th1 priming (Refs.7, 19 ; Fig. 3A), it has been shown that the levels of Hlx fall in primary Th1 cell cultures after the first few days (19). It was also reported that levels of Hlx in a Th1 clone were significantly lower than in primary Th1 cultures (19). Despite the persistent expression of substantial amounts of T-bet in Th1 clones (Fig. 3A; (4)), we also found that the levels of Hlx in two other Th1 clones drops below the level of early Th1 cultures (Fig. 3, A and B). Analysis of two different Th1 clones revealed that Hlx levels may drop slightly below developing Th1 cells or may even fall to levels below a Th2 clone (Fig. 3, A and B), despite maintaining heritable IFN-
activity (Fig. 3C). The lack of defect in IFN-
activity from delayed introduction of DN Hlx (Fig. 2E) is thus quite consistent with the ability to experimentally separate Hlx expression from heritable IFN-
activity in a mature Th1 clone. The persistent expression of T-bet without Hlx in a Th1 clone is also consistent with the apparent lack of a sufficient or necessary role for Hlx in IL-12R
2 expression (Ref.7 ; Fig. 2D). Although IL-12R
2 expression continues to remain dependent on T-bet in mature Th1 cells (7), the absence of Hlx in such cells would not be predicted to be of consequence, based on the negligible effect of overexpression or antagonism of Hlx on the IL-12R
2 target (Ref.7 ; Fig. 2D).
|
The dispensability of an inducing activator for the maintenance of gene expression has also been recently addressed in the Th2 fate. Deletion of Gata3 during Th2 development perturbed establishment of transcriptional competence of IL-4 activity (12, 13). In contrast, deletion of Gata3 in mature Th2 cells had a moderate (12) or minimal (13) effect on maintenance of IL-4 activity. The apparent differences in those studies may have been attributable to the timing of deletion. To explore this, we fashioned a DN GATA-3 construct (Fig. 4A) and performed a kinetic analysis. Indeed, introduction of DN GATA-3 at day 1 resulted in a significant decrease in the frequency and intensity of IL-4-expressing cells (Fig. 4B). By day 21 of Th2 maturation, however, DN G3 had minimal effect on the expression of IL-4 (Fig. 4B). Intermediate time points exhibited intermediate defects consistent with a progressive stability in il4 (data not shown). Thus, establishment and maintenance of IL-4 activity in Th2 cells are experimentally distinguishable by their sensitivity and recalcitrance to DN GATA-3, respectively.
|
|
expression in mature Th2 cells. T-bet-VP16, however, could induce substantial secretion of IFN-
and converted the majority of transduced cells into brightly staining, IFN-
-positive cells. None of the interventions significantly repressed IL-4 expression (data not shown). The dual expression of IL-4 and IFN-
also suggested that we were not simply providing a selection mechanism for contaminating Th1 cells, but rather de-repressing IFN-
in maturing Th2 cells. Thus, mature Th2 cells become recalcitrant to the inducing factors, T-bet plus Hlx, which can mediate efficient IFN-
maturation in developing Th2 cells. By targeting strong activators, however, the progressive restrictions that are imposed on the forbidden cytokine gene may be capable of being more efficiently overcome. | Discussion |
|---|
|
|
|---|
|
provides novel evidence for the viability of genetic strategies to intervene during disease processes mediated by fully differentiated helper T cells.
It is curious that within the same cell type, a single activator might become dispensable for one target but remain continually required for another. In mature Th1 cells, T-bet seems to be essential to maintain IL-12R
2 (7), whereas GATA-3 seems to be essential for ongoing IL-5 and IL-13 expression in mature Th2 cells (12, 13). Whether the behavior of becoming activator independent reflects the need to have more rapid expression of one gene compared with another, or is simply a feature of the structural elements of the gene remains unresolved. Likewise, the mechanisms responsible for locking in the activity or silencing of cytokine genes during helper T cell maturation are still incompletely defined. We do not yet know whether the stability we observe is truly epigenetic, maintained by self-propagating chromatin marks, or is more accurately genetic, maintained by trans-activators other than T-bet, Hlx, or GATA-3, and conventional repressors acting at negative cis-elements (32). In either case, it is remarkable, although not fully explicable, that recruitment of an engrailed repression domain has such a minor effect on cytokine expression in mature cells. Understanding the genetic and biochemical basis for the transition between plasticity and inflexibility in gene activity or silencing should, however, enable the rational design of approaches to switch what were previously thought to be irrevocable cell fates.
| Acknowledgments |
|---|
| Disclosures |
|---|
|
|
|---|
| Footnotes |
|---|
1 This work was supported by the National Institutes of Health (Grants AI42370 and AI53827) and the Abramson Family. ![]()
2 Address correspondence and reprint requests to Dr. Steven L. Reiner, Abramson Family Cancer Research Institute, University of Pennsylvania, Building BRB II/III, Room 414, 421 Curie Boulevard, Philadelphia, PA 19104. E-mail address: sreiner{at}mail.med.upenn.edu ![]()
3 Abbreviations used in this paper: DN, dominant negative; RV, retrovirus; dEnR, Drosophila engrailed repressor; MFI, mean fluorescence intensity. ![]()
Received for publication June 1, 2005. Accepted for publication August 30, 2005.
| References |
|---|
|
|
|---|
production in CD4 and CD8 T cells. Science 295:338.-342.
expression. J. Immunol. 172:114.-122. This article has been cited by other articles:
![]() |
J. Dong, C. Ivascu, H.-D. Chang, P. Wu, R. Angeli, L. Maggi, F. Eckhardt, L. Tykocinski, C. Haefliger, B. Mowes, et al. IL-10 Is Excluded from the Functional Cytokine Memory of Human CD4+ Memory T Lymphocytes J. Immunol., August 15, 2007; 179(4): 2389 - 2396. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Matsuda, T. C. George, J. Hagman, and L. Gapin Temporal Dissection of T-bet Functions J. Immunol., March 15, 2007; 178(6): 3457 - 3465. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Becknell, T. L. Hughes, A. G. Freud, B. W. Blaser, J. Yu, R. Trotta, H. C. Mao, M. L. Caligiuri de Jesus, M. Alghothani, D. M. Benson Jr, et al. Hlx homeobox transcription factor negatively regulates interferon-{gamma} production in monokine-activated natural killer cells Blood, March 15, 2007; 109(6): 2481 - 2487. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kiwamoto, Y. Ishii, Y. Morishima, K. Yoh, A. Maeda, K. Ishizaki, T. Iizuka, A. E. Hegab, Y. Matsuno, S. Homma, et al. Transcription Factors T-bet and GATA-3 Regulate Development of Airway Remodeling Am. J. Respir. Crit. Care Med., July 15, 2006; 174(2): 142 - 151. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |